XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.540
-0.035 (-1.36%)
At close: Apr 28, 2026, 4:00 PM EDT
2.545
+0.005 (0.20%)
After-hours: Apr 28, 2026, 4:10 PM EDT
XBiotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | - | - | - | 4.01 | 18.39 | Upgrade
|
| Revenue | - | - | - | 4.01 | 18.39 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -78.20% | -58.19% | Upgrade
|
| Cost of Revenue | - | - | - | 0.65 | 5.82 | Upgrade
|
| Gross Profit | - | - | - | 3.36 | 12.57 | Upgrade
|
| Selling, General & Admin | 8.3 | 4.71 | 4.66 | 6.31 | 9.39 | Upgrade
|
| Research & Development | 47.39 | 37.76 | 32.85 | 31.54 | 28.27 | Upgrade
|
| Operating Expenses | 55.69 | 42.47 | 37.51 | 37.85 | 37.66 | Upgrade
|
| Operating Income | -55.69 | -42.47 | -37.51 | -34.49 | -25.08 | Upgrade
|
| Interest Expense | -0.09 | -0.81 | - | - | - | Upgrade
|
| Interest & Investment Income | 5.68 | 9.81 | 10.42 | 3.82 | 0.47 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.33 | -5.53 | 1.89 | -2.8 | -0.71 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.9 | 0.43 | 0.88 | -0.12 | -0.13 | Upgrade
|
| EBT Excluding Unusual Items | -45.86 | -38.56 | -24.31 | -33.59 | -25.46 | Upgrade
|
| Other Unusual Items | 0.56 | - | - | - | - | Upgrade
|
| Pretax Income | -45.31 | -38.56 | -24.31 | -33.59 | -25.46 | Upgrade
|
| Income Tax Expense | 0.24 | -0.03 | 0.24 | -0.69 | -8.04 | Upgrade
|
| Net Income | -45.54 | -38.53 | -24.56 | -32.9 | -17.41 | Upgrade
|
| Net Income to Common | -45.54 | -38.53 | -24.56 | -32.9 | -17.41 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | Upgrade
|
| Shares Change (YoY) | 0.09% | 0.07% | -0.00% | 1.32% | -2.53% | Upgrade
|
| EPS (Basic) | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 | Upgrade
|
| EPS (Diluted) | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 | Upgrade
|
| Free Cash Flow | -40.21 | -32.27 | -19.09 | -15.41 | 65.92 | Upgrade
|
| Free Cash Flow Per Share | -1.32 | -1.06 | -0.63 | -0.51 | 2.19 | Upgrade
|
| Gross Margin | - | - | - | 83.77% | 68.36% | Upgrade
|
| Operating Margin | - | - | - | -860.10% | -136.36% | Upgrade
|
| Profit Margin | - | - | - | -820.45% | -94.67% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -384.26% | 358.38% | Upgrade
|
| EBITDA | -54 | -40.73 | -35.77 | -31.88 | -22.43 | Upgrade
|
| EBITDA Margin | - | - | - | - | -121.96% | Upgrade
|
| D&A For EBITDA | 1.69 | 1.75 | 1.74 | 2.61 | 2.65 | Upgrade
|
| EBIT | -55.69 | -42.47 | -37.51 | -34.49 | -25.08 | Upgrade
|
| EBIT Margin | - | - | - | - | -136.36% | Upgrade
|
| Revenue as Reported | - | - | - | 4.01 | 18.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.